Results: Compared to those with no C282Y variant, C282Y homozygotes were at increased risk of total hip replacement (HR 1.94, 95% CI 1.04-3.62). The association was stronger for men (HR 3.34, ) than for women (HR 1.22, ) (p for interaction = 0.21). Only 3 C282Y homozygotes had total knee replacements; the HR was 0.51 (95% CI 0.16-1.57). C282Y/H63D compound heterozygosity was not related to the risk of total hip or knee replacement. Conclusions: HFE C282Y homozygosity was associated with increased risk of total hip replacement for osteoarthritis for men but not for women. The mechanism for this is unknown and the findings need to be confirmed in future studies.
THE mtDNA HAPLOGROUPS INFLUENCE THE PROGRESSION OF OSTEOARTHRITIS (OA)
Purpose: To analyze the influence of the mtDNA haplogroups in the progression of the osteoarthritis (OA) disease. Methods: The DNA of 282 knee and/or hip OA samples from Hospital Universitario A Coruña was isolated to obtain their mtDNA haplogroups. Knee and/or hip radiographs from all these samples were obtained at two stages of the OA disease of at least 36 months between them, and evaluated according to the K/L scale from grade 0 to IV. Statistical analyses included Kaplan-Meier survival curves for each haplogroup or cluster tested, as well as Cox regression models taking into account another variables such as gender, haplogroup (or cluster) and body mass index (BMI). Results: For this study, two types of progression were established: OA progression and severity progression. We considered OA progression when a patient evolved from K/L grade 0-I to K/L grade II-III or K/L grade IV, and from K/L grade II-III to K/L grade IV, in at least one of the joints analyzed. The results obtained showed that the OA progression varies significantly according to the mtDNA haplogroups (p = 0.030), and the main differences were detected when compared patients that belonged to the cluster TJ (better progressors) with patients of the cluster KU (worse progressors) (p = 0.083) (Figure 1 ). On the other hand, we considered severity progression when a patient evolved to knee or hip prosthesis from an initial K/L grade III or less. In this case, the results obtained showed that patients carrying the most common mtDNA haplogroup H had a worse severity progression than non-H patients (p = 0.035) ( Figure 2) . The Cox regression model also showed that males evolved worse than females (p = 0.028).
Conclusions:
The mtDNA haplogroups influence the progression of OA; these results strength the role of the mitochondria in the OA disease. 
